ReviewEndocrinology and metabolism (Seoul, Korea)2019

A Review of the Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Lean Body Mass in Humans.

Jack Alistair Sargeant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.